Tilray Brands, Inc. (TLRY) stock
TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3087% below fair value
$2.35+0.01 (+0.43%)
Close on Nov 17, 2026Market cap $347.30MP/E –Yield –
Tilray Brands price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Tilray Brands's price to sales ratio was 0.4× on Nov 11, 2026, against 1.1× a year earlier. Over the last 5 years it ranged from 0.4× to 21.6×, with a median of 1.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | −0.8 |
| 2025 | Dec 31, 2025 | 1.2× | −0.1 |
| 2024 | Dec 31, 2024 | 1.4× | −1.2 |
| 2023 | Dec 29, 2023 | 2.6× | −0.1 |
| 2022 | Dec 30, 2022 | 2.6× | −1.6 |
| 2021 | Dec 31, 2021 | 4.2× | −0.7 |
| 2020 | Dec 31, 2020 | 5.0× | −5.9 |
| 2019 | Dec 31, 2019 | 10.8× | −160.7 |
| 2018 | Dec 31, 2018 | 171.5× | – |
See a number that looks wrong?